Verisol® Clinical Studies
Two studies with participation from 180 women between the age of 35 and 60 with normal skin were performed to establish the efficiency of Verisol® Bioactive Collagen Peptides
Skin wrinkles were objectively measured in all subjects, before starting the treatment, after 4 and 8 weeks as well as 4 weeks after the last intake (4-week regression phase). The aging parameters include skin elasticity and wrinkle volume.
Eye wrinkle volume decreased by 20% on average ( with the HIGHEST wrinkle reduction at 49%)
Procollagen Type 1 content increased by 65%
Elastin content increased by 18%
Eye wrinkle volume maintained a decreased amount of 18% 4 weeks after the last in-take.
* 8 weeks clinical study of daily oral VERISOL Treatment (2500mg) in comparison to placebo administration. Skin Pharmacology and Physiology Vol. 27, No. 1,1014 Issue Release Date: August 2013. Department of Dermatology, University of Kiel, and CRI, Collagen Research Institute, Kiel and Skin Ingestion and Technology, Hamburg, Germany.
VERISOL Bioactive Collagen Peptides are registered trademarks of GELITA AG, Germany.
Lutein is an important nutrient that our bodies deposit in our eyes and skin to help protect them from the harmful effects of blue light.
Without the light-filtering protection of lutein, blue light penetrates the deepest layers of our skin and forms damaging free radicals.
Maintains healthy and youthful-looking skin.
Protects skin from oxidative stress.
Protects skin from aging effects of the sun.
The benefits of FloraGLO® Lutein
Fortigel® Clinical Studies
Helps to increase joint mobility
Promotes optimal physical performance
Supports cartilage tissue regeneration